Satish Kumar Devarapu: Returning from ISTH 2026 with New Perspectives
Satish Kumar Devarapu, Chief Scientific Officer at PreviPharma, shared a post on LinkedIn:
”ISTH 2026 Paris.
Some conferences leave you with new knowledge. Others leave you with new perspectives. ISTH 2026 in Paris gave me both.
Over the past week, I had the privilege of learning from outstanding scientific presentations, engaging in inspiring discussions, and reconnecting with colleagues while meeting many new peers and experts from around the world. These conversations reminded me that scientific progress is built not only through research, but also through collaboration and the willingness to learn from one another.
One moment that particularly stayed with me was seeing young mothers attending the congress with their infants. The thoughtful accommodations provided by the organizers created an environment where parenthood and professional development could coexist. It was a powerful reminder that an inclusive scientific community is one where everyone has the opportunity to contribute and thrive.
Paris is known worldwide for the Eiffel Tower, but for me this visit was equally about celebrating the city’s remarkable scientific heritage. Visiting the resting place of Marie Curie to pay my respects and touring the Pasteur Institute were deeply meaningful experiences. Standing in places where pioneers transformed medicine and science was both humbling and inspiring, reinforcing why our work today matters for the generations to come.
I return home with fresh scientific insights, renewed motivation, and new collaborations that I hope will translate into better research and better patient care.
My sincere thanks to the ISTH 2026 organizers for delivering an exceptional congress and for fostering a welcoming, inclusive, and inspiring environment for the global scientific community.”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 10:32Natalie Arnold: The Lp(a) Puzzle – Why Lower Levels May Not Tell the Whole Story
-
Nov 9, 2026, 10:22ISBT Opens Applications for the I TRY IT Programme 2027
-
Nov 9, 2026, 10:08Ibrahim Mansoor: Rare Tests, Common Diseases – Rethinking Autoimmune Diagnostics
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services